The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020
Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study Source: Eur Respir J 2004; 24: Suppl. 48, 187s Year: 2004
Effect of a quality improvement plan on the outcome of patients with community acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003
Frequency of antibiotic resistance and outcomes in severe community acquired pneumonia due to Streptococcus pneumoniae Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization Source: Eur Respir J 2006; 28: Suppl. 50, 166s Year: 2006
Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005
Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Influence of medical comorbidities in patients with community acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011
Can CAP guideline adherence improve patient outcome in internal medicine departments? Source: Eur Respir J 2008; 32: 902-910 Year: 2008
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003
The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005